The K562 cell line, established from a CML patient, harbors an abnormal fusion gene BCR-ABL encoding a tyrosine kinase, which promotes both cell proliferation and DR through several pathways [32, 33]. Here, ABL1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.